From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Supply@Me Capital – Endless delays and the latest the Dog Ate My Homework excuse

By Tom Winnifrith | Saturday 9 October 2021


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


The whole team at ShareProphets has long been sceptical about the fraud that is Supply@ME Capital (SYME) and the excuses that CEO Alessandro Zamboni regularly trots out to explain the endless delays in inventory monetisation.  Whilst some of the Bulletin Board Morons that have invested in this scam are slowly developing some sense of scepticism others simply swallow Alessandro’s latest bullshit explanation even when the excuse doesn’t stand up to even minor scrutiny.  Take for instance the latest explanation for the non-purchase of the FinTech bank as set out in interim results of 30 September 2021 below:

Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

AAU

Gold up Ariana down

Saturday »

AVCT

Cassava, A warning to Avacta Sharehoders 

Friday »

ALU

Alumasc Group – a growth Buy

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

 

APH

Alliance Pharma – a recovery Buy?

Time left: 17:45:29